Nyxoah SA (NYXH) Actualités

Publication relating to transparency notifications

                REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Publication relating to transparency notifications

                REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandFirst patients implanted with Genio...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium –...

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024

REGULATED INFORMATIONNovember 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Publication relating to transparency notifications

                 REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating ResultsFDA approval on track for...